The Menzies Institute of Recovery from Addiction or MIRA, is ARCA’s division offering Inpatient Residential Programs. Based on a comprehensive model of treatment which includes medical detoxification and anti-craving medications, along with psychiatric and behavioral therapy, our inpatient treatment program is individualized to meet your needs. Alcohol and drug addiction is an illness. And just like any illness, it requires comprehensive medical and behavioral treatment.
With private rooms, linen and food service, access to the outdoor patio and recreational room, nutritional counseling, and various wellness therapies, the ARCA Inpatient Residential Programs at MIRA offer a medical approach to the treatment of addictive disorders in a caring, comfortable environment.
The main features of the ARCA Inpatient Residential Programs at MIRA encompass the following components:
- Inpatient medical detoxification for patients seeking treatment for alcohol or drug addiction
- A psychiatric assessment and psychiatric treatment if appropriate
- After a medical detoxification, patients will be transitioned to the appropriate anti-craving medications to protect them from relapsing when they return home to continue treatment in an Outpatient Treatment Program
- Residential Treatment following medical detoxification for patients requiring longer periods of residential treatment
- Patients will be discharged to an appropriate Outpatient Treatment Program, and, if medically eligible, will be placed on sustained release anti-craving medications to reduce the chance of relapse
The benefits include:
- The ARCA Inpatient Residential Program’s medical detoxification at MIRA will significantly reduce or eliminate the problems encountered in Outpatient Treatment Programs of transitioning patients from detoxification medications to non-addicting, anti-craving medications
- The high recidivism rates, particularly in the early phase of Outpatient Treatment Programs, will be significantly reduced because of the protective benefits of the anti-craving medications administered during the Inpatient Residential Program
- Patients will not be required to spend 28 days or longer at a treatment center, reducing the stress and cost involved in being away from work and family
- The shorter stay in the ARCA Inpatient Residential Program at MIRA will reduce the overall cost to the patient compared to long-term residential programs
- Patients will be able to return to work earlier, thus reducing the loss of income and also maintaining the confidentiality that could be inadvertently breached when patients are away from work and home for an extended period of time
The ARCA Inpatient Residential Program at MIRA is the culmination of over twenty-five years of close association and experience in the field of addiction medicine by Mr. Percy Menzies, the founder of the institution. The ARCA Inpatient Residential Program at MIRA envisions a treatment that encompasses the proven advances made in the understanding of the neurochemistry of chemical dependency and addictive disorders by offering integrated and individualized treatment programs designed to minimize the duration of Inpatient Residential treatment and maximizing the duration of Outpatient Treatment. The ARCA Inpatient Residential Program at MIRA will have several clinical advantages that not only advance the field of addiction treatment, but may set a new standard of care. Read more below to further understand why we offer the type of inpatient residential treatment at MIRA that we do.
ARCA Combines Science, Knowledge, and Compassion Into Each Inpatient Residential Treatment Program at MIRA To Aid You On Your Journey Back To A Sober Life
Healing the Brain, the Body, and the Mind
During ARCA’s Inpatient Residential Treatment Program at MIRA, every patient will be evaluated by the medical team and the medical detoxification will greatly reduce or eliminate the uncomfortable withdrawal symptoms that can force patients to relapse. Effective treatment of the physical symptoms allows the patient to move to the next critical step of behavioral changes. A team of psychiatrists, therapists, and counselors will work with you so that you can build the skills to regain and restore control over the destructive behaviors associated with alcohol or drug use. You will also have access to exercise equipment, nutritional counseling, and other wellness programs and activities.
Going Beyond Addiction Treatment
Smoking has no place in the treatment of chemical dependency and addiction during an effective inpatient residential treatment program, and smoking should be considered substance substitution. Our facility is strictly non-smoking, and we will offer you help to quit smoking. Our services include acupuncture, auricular therapy, and nicotine replacement. Our approach to treatment does not subscribe to the conventional belief of not treating smoking while you are in treatment for alcohol or drug use disorder.
Anticraving Medications like Vivitrol are the Cornerstone of Treatment
Not all anti-craving medications are created equal. We strongly advocate the use of non-addicting medications like Naltrexone during treatment, and especially when you return. The introduction of the monthly injectable form of Naltrexone – VIVITROL – is the strongest protection from relapse when you return home. Followed up with ARCA’s Outpatient Treatment Programs, the Inpatient Residential Treatment Program at MIRA is most effective when coupled with Vivitrol injections.
How Long Should You Stay in an Inpatient Residential Treatment Program for drugs and alcohol?
We strongly believe in providing an individualized, inpatient residential treatment program. There is no one-size-fits-all treatment program. The comprehensive approach of medical detoxification, anti-craving medications, psychiatric therapy, and behavioral therapy allows patients to return home in periods ranging from 10 to 20 days. We will not rush the discharge nor prolong your stay. The appropriate discharge planning will be done to make a smooth transition into an aftercare program to begin long-term recovery.
Following You Home
The recovery experienced in the inpatient residential treatment program has to be maintained when you return home. Every eligible patient will be discharged on an injection of VIVITROL. We will work diligently to match you with the right aftercare program that subscribes to the ARCA approach to treatment. We will work with your insurance provider and arrange for your monthly VIVITROL injections.
Whether this is your first time or fifth time in treatment, we promise you a treatment program that is scientifically proven, provided by a trained and knowledgeable staff, with the goal to help you achieve a lifelong recovery when you return home.
Chemical Dependency and addiction occurs in the patient’s natural home environment, and the conditioning of the addiction is reinforced by the cues and triggers surrounding the patient every day. In the past, it seemed logical that the best way to extinguish the conditioning of the addiction was taking the patient away from their natural home environment for an extended period of time, usually one to three months. During this time, the patient would learn new relapse prevention skills most often through the Twelve-Step approach. There is considerable scientific evidence that this episodic approach does not work well when patients return to their natural home environment, which is still filled with cues and triggers of past alcohol or drug use. This often leads to relapse, and yet this method of treatment continues to be the mainstay of many programs.There is a general agreement that alcoholism and drug addiction is a chronic, progressive, and relapsing illness, but the present treatment is episodic, experiential, and non-medical. Treatment recommendations are often based on the recovery experience of the treatment professional, who is in recovery themself. Alcoholism is overwhelmingly treated through self-help groups like Alcoholics Anonymous (AA) and the Twelve-Step approach. Currently, less than 3% of patients are prescribed anti-craving medications. Opioid addiction treatment is dominated by the acceptance of substance substitution treatment, using opioid-based medications like Methadone, which is administered in highly-regulated clinics. The use of Buprenorphine is gaining greater acceptance, which is a medication that can be prescribed in a physician’s office by a physician who has completed the required training to receive DEA exemption.
The relationship between the treatment community – those on the frontline helping patients achieve recovery – and the medical community is very tenuous, and characterized by mutual distrust and sometimes hostility. The chasm is largely due to the limited understanding of the causes of chemical dependency and addiction, and the exploitation of victims desperately seeking help with remedies and medications that cause harm. The treatment of chemical dependency and addiction remains on the outskirts of the field of medical science, with very little progress being made to bridge the treatment gap. Schools training social workers place little or no emphasis on pharmacotherapy to treat chemical dependency, and medical schools pay scant attention to properly training physicians to treat the immense problem of addiction afflicting our society.
Few long-term residential treatments have developed a program that successfully protects patients from relapsing when they return home. The coping skills learned during the long-term residential treatment program and the inner resolve of the patient to abstain from alcohol and drugs do not create a successful model of treatment. When a patient returns home and encounters the cues and triggers of past alcohol and drug use, these cues and triggers are magnified by the force of the deprivation effect experienced when the patient is away in a long-term residential treatment program. This phenomenon is often referred to as Conditioned Abstinence, and is recognized as a major contributing factor to relapse.
To overcome this problem, scientists working for the United States Federal Government developed the first non-addicting, anti-craving medication in the early 1970s called Naltrexone. This medication protects patients from accidentally using alcohol or opioids when they return home from a long-term residential treatment program. Long-term programs are effective during the medical detoxification, but not during the transition to anti-craving medications that assist in sustaining long-term recovery.
Outpatient treatment programs originated more recently, where patients receive treatment in their natural home environment. These programs allow patients to receive treatment in their natural home environment, and help the patient avoid long hiatuses from work or school. These programs were designed under increasing pressure from health insurance companies to reduce expenditures, but also proved to be effective treatment programs due to the advances in pharmaceutical science and addiction medicine.
The scientific advances in the understanding of the neurobiology of the brain in regards to chemical dependency and addiction have led to the development of a new class of pharmaceutical medications. These new medications are either non-addicting or have lower abuse potential than medications used in the past. Similarly, considerable advances have been made in behavioral health therapies. Yet neither these medications nor therapies have gained much traction against the Twelve-Step approach and substance substitution therapy. Our Inpatient Residential Program embraces these advances in pharmaceutical science and addiction medicine to provide a comprehensive approach to treatment.
An Outpatient Treatment Program that Follows You Home
The ultimate test of any inpatient treatment program is how you do when you return home. The most vulnerable time for patients is the last few days of residential treatment for drugs and alcohol and the first few days and weeks of returning home. What makes returning home a vulnerable time?
You are returning to the all-too-familiar landscape of past alcohol or drug use. Think of it this way—you are just a few days from returning home. Some of the old voices return that were caused by the chronic illness of alcoholism and drug addiction. You are surrounded by reminders, triggers, or “traps”: friends, places, times of the day, days of the week, music, smells associated with alcohol or drug use, feelings of euphoria and escape. All of these are powerful incentives to reignite cravings.
ARCA wants you to know that the skills you have acquired and experienced in the MIRA Inpatient Residential Treatment Program are an incredible jump-start to recovery, but it’s only the beginning. That’s why we encourage our patients to continue treatment in ARCA’s Outpatient Treatment Programs.